Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644806 · ClinicalTrials.gov registry record · NA
Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction
A NA study, sponsored by Old Dominion University.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07644806 is a NA study that has not yet begun recruiting, run by Old Dominion University. The registered enrollment target is 40 participants.
The verdict
NCT07644806, a NA study, has not yet begun recruiting, sponsored by Old Dominion University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.
Interventions
- OTHER Extra-virgin olive oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07644806
The ClinicalTrials.gov registry entry for NCT07644806 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Old Dominion University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Extra-virgin olive oil is the first listed.
NCT07644806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07644806 about?
NCT07644806 is a clinical study titled "Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction". The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also det...
What is the current status of trial NCT07644806?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-07-01. Estimated completion is 2028-03-31.
What interventions are being tested in trial NCT07644806?
The interventions under investigation include: Extra-virgin olive oil (OTHER).
Who is sponsoring clinical trial NCT07644806?
This trial is sponsored by Old Dominion University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.